Interested in becoming an ACAAI member? Learn more about the benefits of membership and find your place in the College.

ePoster Schedule - Research



CLICK HERE FOR ONLINE VIEWING OF EPOSTERS

RESEARCH EPOSTER SCHEDULE

PRESENTATION
DATE

CATEGORY

MONITOR

PRESENTATION
TIME

PRESENTATION
ID

ABSTRACT_TITLE

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

3:00 pm PT

P001

Skin test for immediate hypersensitivity reaction to iodinated contrast media: an individual patient data meta-analysis

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

3:15 pm PT

P002

13.2 mg Intranasal Epinephrine Treatment In Congestion Shows Increased Bioavailability Without Pharmacokinetic And Pharmacodynamic Correlation

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

3:30 pm PT

P003

Safety of Anti-SARS-CoV-2 Monoclonal Antibody Therapies: Clinical Characteristics and Outcomes of Adverse Drug Reactions

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

3:45 pm PT

P004

Impact of Angioedema on the Pharmacokinetics of Epinephrine Following Administration via Sublingual Film

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

4:00 pm PT

P005

Epinephrine Administered via Sublingual Film, Manual Injection, or Auto-Injectors in Healthy Adults: Pharmacodynamic Results

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

4:15 pm PT

P006

NSAID Allergy Labeling and Postpartum Opioid Utilization Following Vaginal or Cesarean Delivery

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

4:30 pm PT

P007

Acute Allergic Rhinitis Increases Endogenous Epinephrine Resulting in Increased Heart Rate

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

4:45 pm PT

P008

Risk Factors for Failing Penicillin Challenge Among Pediatric Patients at a Single Institution

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

5:00 pm PT

P009

Factors Associated with Inequity in Penicillin Allergy Evaluation in a Single-Payer System

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

5:15 pm PT

P010 - COMMUNITY GRANT

Patient Perspectives on Penicillin Allergy Evaluation During Pregnancy: A Qualitative Study

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

5:30 pm PT

P011

Incidence and Predictors of Cutaneous Reactions to the COVID-19 Booster Vaccine

Friday, Nov 10

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

5:45 pm PT

P012

A Single-Period, Single-Dose Study of the Pharmacokinetics of Epinephrine After Administration ARS-1 to Pediatric Subjects

Friday, Nov 10

Aerobiology, Allergens, Allergen Extracts

Monitor 21

3:00 pm PT

P030

Comparative Analysis of Aerobiological Rotating Impaction Devices: Rotorod vs Rotoslide

Friday, Nov 10

Aerobiology, Allergens, Allergen Extracts

Monitor 21

3:15 pm PT

P031

Allergic Sensitization to Inhalant Allergens in the United States

Friday, Nov 10

Aerobiology, Allergens, Allergen Extracts

Monitor 21

3:30 pm PT

P032

A Two Stage Artificial Intelligence (AI) Detection And Classification Model For Pollen Grain (PG) Counting.

Friday, Nov 10

Allergy Diagnostics and Immunotherapy

Monitor 21

3:45 pm PT

P040

Briquilimab, an anti-CD117 antibody, prevents passive systemic anaphylaxis in mice expressing chimeric human/mouse CD117

Friday, Nov 10

Allergy Diagnostics and Immunotherapy

Monitor 21

4:00 pm PT

P041

Allergen sensitization patterns in patients at a Federally Qualified Health Center

Friday, Nov 10

Allergy Diagnostics and Immunotherapy

Monitor 21

4:15 pm PT

P042

Optimizing Utilization of Venom Immunotherapy in an Era of Venom Extract Shortages

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

3:00 pm PT

P050

HAE Prophylaxis by Targeting Prekallikrein With siRNA- Phase 1 Interim Safety Outcomes and Prekallikrein Levels

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

3:15 pm PT

P051

Garadacimab protects against hereditary angioedema attacks from Week 1 in pivotal Phase 3 VANGUARD study

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

3:30 pm PT

P052

Healthcare Experiences Prior to Hereditary Angioedema Diagnosis in Underrepresented Racial/Ethnic Groups in the United States

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

3:45 pm PT

P053

Two-Year Analysis of the Donidalorsen Phase 2 Open-Label Extension Study in Patients With Hereditary Angioedema

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

4:00 pm PT

P054

Two-Year Analysis of Donidalorsen Taken Every 8 Weeks (Q8W) in Patients With Hereditary Angioedema

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

4:15 pm PT

P055

Flow-Cytometry Based Immunoassay Is A Highly Sensitive Method To Quantitate Functional C1-Inhibitor In HAE Patients

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

4:30 pm PT

P056

Real-World Outcomes In Patients With HAE Receiving Lanadelumab Long-Term Prophylaxis For 3 Years Or Longer

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

4:45 pm PT

P057

Burden of Illness in Adult Patients With Hereditary Angioedema: Results From a Multinational Survey

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

5:00 pm PT

P058

Bradykinin Measurement By Mass-Spectrometry Correlates With Angioedema Attack Frequency In Bradykinin-Mediated Angioedema

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

5:15 pm PT

P059

Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) – A Real-World ACARE Survey

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

5:30 pm PT

P060

Analysis Of Safety Data Of Remibrutinib From Completed Phase 2 Studies In Inflammatory Immune-Mediated Diseases

Friday, Nov 10

Angioedema/Urticaria

Monitor 12

5:45 pm PT

P061

Diagnostic Pathway Differences Across Physician Specialties for Patients with Chronic Spontaneous Urticaria: Real-World Survey

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

3:00 pm PT

P072

Remibrutinib Provides Fast and Clinically Important Improvement of Chronic Spontaneous Urticaria Disease Activity

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

3:15 pm PT

P073

Impact of Baseline Angioedema and IgE on Response to Omalizumab in Chronic Spontaneous Urticaria

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

3:30 pm PT

P074

Remibrutinib Treatment Has No Impact on Blood Counts in Patients with Chronic Spontaneous Urticaria

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

3:45 pm PT

P075

Dupilumab improves itch and urticaria activity across several CSU patient subpopulations: LIBERTY-CSU CUPID Study A

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

4:00 pm PT

P076

Time to Sleep Improvement in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

4:15 pm PT

P077

Burden on Caregivers to Pediatric Patients With Hereditary Angioedema: Results From a Multinational Survey

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

4:30 pm PT

P078

Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment With Them

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

4:45 pm PT

P079

Systemic Manifestations During Symptomatic Episodes In Chronic Spontaneous Urticaria: Results From The Urticaria Voices Study

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

5:00 pm PT

P080

Remibrutinib Achieves Clinically Significant Response in Chronic Spontaneous Urticaria Patients Regardless of Prior Oral Treatments

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

5:15 pm PT

P081

Deucrictibant immediate-release capsule reduces time to end of progression of hereditary angioedema attacks’ manifestations

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

5:30 pm PT

P082

Berotralstat Reduced Attack Rates In Patients With Suspected Bradykinin-Mediated Angioedema: Real-World Outcomes

Friday, Nov 10

Angioedema/Urticaria

Monitor 13

5:45 pm PT

P083

Association of COVID Vaccine Manufacturer to Vaccine Related Urticaria

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

3:00 pm PT

P100

Wildfire-associated Increase In Reliever Use Among US Asthma Patients: Data From A Digital Health Platform

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

3:15 pm PT

P101

Tezepelumab Reduces All Key Inflammatory Biomarker Levels In Patients With Severe Allergic And Eosinophilic Asthma

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

3:30 pm PT

P102

Tezepelumab Reduced OCS Use In OCS-dependent Patients With Severe Asthma: Phase 3b WAYFINDER Interim Results

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

3:45 pm PT

P103

Benralizumab is Effective in Reducing COPD Exacerbations in Patients with Asthma and Concomitant COPD

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

4:00 pm PT

P104

Timing Of Exacerbations With Tezepelumab Versus Placebo In Patients With And Without Symptomatic Perennial Allergy

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

4:15 pm PT

P105

Recent Real-World Biologic Utilization Among Adults With Severe Asthma: Data From The CHRONICLE Study

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

4:30 pm PT

P106

Age, Sex, Obesity, and Controller Therapy Moderate the Relationship between Pediatric Asthma Exacerbations and COVID-19

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

4:45 pm PT

P107

Tezepelumab Efficacy In Patients With Severe Asthma By Blood Eosinophil Count And Perennial Allergy (DESTINATION)

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

5:00 pm PT

P108

Statewide Burden of Asthma across the United States Between 1990-2019: Systematic and Comparative Benchmarking Study

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

5:15 pm PT

P109

Unmet Educational Needs in Asthma Management Guidelines: How to Bridge the Gap?

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

5:30 pm PT

P110

Primary Care Physician Referral Patterns and Awareness of Biologic Therapy for Uncontrolled Asthma

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 14

5:45 pm PT

P111

The Effect of COVID-19 on Pediatric Asthma ICU Admissions at a Single Center.

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

3:00 pm PT

P122

Heterogeneous characteristics of severe asthma patients initiating benralizumab in a real-world setting: the ZEPHYR-4 study

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

3:15 pm PT

P123

Effect of the SARS-CoV-2 pandemic on pediatric asthma health-care utilization in an urban tertiary-care hospital

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

3:30 pm PT

P124

Review Of Biologic Efficacy In Patients With Uncontrolled Asthma By Age At Asthma Onset

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

3:45 pm PT

P125

Can Continuing Education Prepare Health Care Providers to Provide Equitable Asthma Care?

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

4:00 pm PT

P126

Impact of Baseline Characteristics on Long-term Response Following Omalizumab Treatment in Patients with Allergic Asthma

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

4:15 pm PT

P127

Performance of the Asthma Impairment and Risk Questionnaire (AIRQ) compared to existing symptom control measures

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

4:30 pm PT

P128

Adherence To Inhaled Medications In Adults With Asthma Evaluated In The ITA, Inhaler Adherence Test

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

4:45 pm PT

P129

Short-acting Beta2-agonist and Systemic/Inhaled Corticosteroid Exposures in US Adolescents and Adults with Asthma

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

5:00 pm PT

P130

Lower Incidence Of Hypereosinophilia With Tezepelumab Treatment Versus Placebo In The PATHWAY And NAVIGATOR Studies

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

5:15 pm PT

P131

Prevalence of Asthma Attacks and Emergency Department Visits Among US Working Adults, 2020–2021

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

5:30 pm PT

P132

Optimizing School Stock Inhaler Programs for Health Equity: Using EPIS Framework and Logic Models

Friday, Nov 10

Asthma, Other Lower Airway Disorders

Monitor 15

5:45 pm PT

P133

Digihaler System Use By Healthcare Professionals And App Connectivity In Asthma Patients: A Pragmatic Study

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

3:00 pm PT

P150

Transcription Factors Impact Differentiation of T-helper Cells in Development of Endometriosis with Infertility

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

3:15 pm PT

P151

Frequency of T-330G IL-2 Gene SNP in SARS-COVID-19 Patients

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

3:30 pm PT

P152

Diagnostic Utility of Streptococcus Pneumonia Titers in a Single Pediatric, Tertiary Hospital and Clinic System

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

3:45 pm PT

P153

Pioglitazone Restored Mouse Lung mRNA Expression of Core Clock, Inflammation and Metabolism-Related Genes

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

4:00 pm PT

P154

Short-term Observation of Safety and Efficacy of Tolerogenic Dendritic Cells Use in Type-1 Diabetes Mellitus

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

4:15 pm PT

P155

Membrane-bound IgE expression on plasmacytoid dendritic cells (pDCs) and B-cells across total serum IgE levels

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

4:30 pm PT

P156

Reduced Bactericidal Permeability-increasing Protein is Found in Post-COVID-19 Syndrome Patients

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

4:45 pm PT

P157

Young Children With Recurrent Respiratory Infections Have Inadequate Pneumococcal Antibodies

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

5:00 pm PT

P158

Structural Characterization of Linear Aliphatic Amine-linked Triaryl Inhibitors of PD-1/PD-L1 With PD-L1 Dimer

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

5:15 pm PT

P159

Characteristics of Disseminated Coccidioidomycosis in Pediatric Patients

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

5:30 pm PT

P160

Autoimmune Disease with Skin Involvement in Patients with Common Variable Immune Deficiency in Western Ukraine

Friday, Nov 10

Clinical Immunology, Immunodeficiency

Monitor 16

5:45 pm PT

P161

Investigating the Association between Mast Cell Activation Syndrome and Irritable Bowel Syndrome

Friday, Nov 10

Food Allergy

Monitor 17

3:00 pm PT

P180

Efficacy and Safety of ADP101 Multifood Oral Immunotherapy in Food-Allergic Patients in the Harmony Trial

Friday, Nov 10

Food Allergy

Monitor 17

3:15 pm PT

P181

Economic burden of food allergy is greater in households with children allergic to more foods

Friday, Nov 10

Food Allergy

Monitor 17

3:30 pm PT

P182

Characterizing Daily Wear Time and Association with Efficacy of VP250 in the EPITOPE Study

Friday, Nov 10

Food Allergy

Monitor 17

3:45 pm PT

P183-COMMUNITY GRANT

National Needs Assessment for an Infant and Toddler Food Allergy Curriculum for Pediatric Residents

Friday, Nov 10

Food Allergy

Monitor 17

4:00 pm PT

P184

Dupilumab Improves Outcomes in Eosinophilic Esophagitis, Regardless of History of Food Allergy or Dietary Elimination

Friday, Nov 10

Food Allergy

Monitor 17

4:15 pm PT

P185

Investigating GI-Variant Alpha-Gal Syndrome in Pediatric Patients Diagnosed with Functional Abdominal Pain

Friday, Nov 10

Food Allergy

Monitor 17

4:30 pm PT

P186

A Shot To Live: Anaphylaxis Curriculum Enhances Efficacy of Epinephrine Administration for Unassigned Administrators

Friday, Nov 10

Food Allergy

Monitor 17

4:45 pm PT

P187

Understanding Perceived Determinants of Food Allergy in a US Population-Based Sample of Children and Adults

Friday, Nov 10

Food Allergy

Monitor 17

5:00 pm PT

P188

Characteristics of an Adult Cohort with Shellfish Allergy: Comparison by Race

Friday, Nov 10

Food Allergy

Monitor 17

5:15 pm PT

P189

Development of Tolerance In Children with Food Allergy

Friday, Nov 10

Food Allergy

Monitor 17

5:30 pm PT

P190

Food allergy-related healthcare utilization and psychosocial burden is greater among children with more food allergies

Friday, Nov 10

Food Allergy

Monitor 17

5:45 pm PT

P191

Predictors of the Psychosocial Burden in Parents of Food Allergic Children

Friday, Nov 10

Food Allergy

Monitor 18

3:00 pm PT

P202

Prevalence and Incidence of Food Allergies in the US General Population

Friday, Nov 10

Food Allergy

Monitor 18

3:15 pm PT

P203

Anaphylaxis Preparedness In Elementary Schools: Knowledge Gaps Remain Despite Frequent Training

Friday, Nov 10

Food Allergy

Monitor 18

3:30 pm PT

P204

Significance of Serum Specific IgE Food Panel Interpretation in Identifying Potential Food Allergies in Children.

Friday, Nov 10

Food Allergy

Monitor 18

3:45 pm PT

P205

Factors Related to Food Allergy in Asian American Children

Friday, Nov 10

Food Allergy

Monitor 18

4:00 pm PT

P206

Racial Disparities in Allergic Disease in an Urban Pediatric Population

Friday, Nov 10

Food Allergy

Monitor 18

4:15 pm PT

P207

Exploring the Interplay of Epinephrine and Needle Phobia: Implications and Strategies

Friday, Nov 10

Food Allergy

Monitor 18

4:30 pm PT

P208

Eosinophilic esophagitis in children: A multicenter study in Mexico evaluating current practices

Friday, Nov 10

Food Allergy

Monitor 18

4:45 pm PT

P209

Managing Food Allergy: Findings from a Nationwide US Survey of Practicing Allergists

Friday, Nov 10

Food Allergy

Monitor 18

5:00 pm PT

P210

Dupilumab Is Efficacious In Patients With Eosinophilic Esophagitis Regardless Of Prior History Of Comorbidities

Friday, Nov 10

Other Allergies and interaction with other disease

Monitor 19

3:00 pm PT

P225

High Prevalence Of Allergy In Patients With Recurrent Pregnancy Loss

Friday, Nov 10

Other Allergy Immunology Education

Monitor 19

3:15 pm PT

P226

Allergy Immunology Fellowship Education During COVID-19 Pandemic

Friday, Nov 10

Other Atopy and COVID-19

Monitor 19

3:30 pm PT

P227

Assessing Severity Of COVID-19 And The Development Of MIS-C In Pediatric Patients With Atopic Disease

Friday, Nov 10

Other Biologic Therapy

Monitor 19

3:45 pm PT

P228

MMR and Varicella Immunization During Dupilumab Therapy

Friday, Nov 10

Other Biologics, Omalizumab, Biosimilars

Monitor 19

4:00 pm PT

P229

Efficacy and safety of Omalizumab Biosimilar in IgE mediated diseases and multimorbidities

Friday, Nov 10

Other Cannabis education for allergists

Monitor 19

4:15 pm PT

P230-COMMUNITY GRANT

Easing the conversation: Cannabis Education for Allergists

Friday, Nov 10

Other Controlled Allergen Environment

Monitor 19

4:30 pm PT

P231

Meta-Analysis Of In-Study Pollen Data In Environmental Exposure Chambers (EEC) From 2019-2022 Demonstrate High Reproducibility

Friday, Nov 10

Other COPD

Monitor 19

4:45 pm PT

P232

Clinical Outcomes Among Individuals With Alpha-1 Antitrypsin Deficiency Enrolled in Medicare Advantage

Friday, Nov 10

Other Drug Allergy

Monitor 19

5:00 pm PT

P233

Allergy to Sulfonamide Increases Risk of Pneumocystis Jiroveci Pneumonia (PJP) in Bone Marrow Transplant Patients

Friday, Nov 10

Other EoE

Monitor 19

5:15 pm PT

P234

Efficacy of dupilumab on facilitated food introduction in Eosinophilic Esophagitis

Friday, Nov 10

Other Eosinophilic Esophagitis

Monitor 19

5:30 pm PT

P235

Case series on the improvement of pediatric Eosinophilic Esophagitis when using Dupilumab for other indications.

Friday, Nov 10

Other Eosinophilic Gastrointestinal Disease

Monitor 19

5:45 pm PT

P236

Characterizing Pediatric Native American Patients with Eosinophilic Gastrointestinal Disease at a Single Tertiary Care Center

Friday, Nov 10

Quality Improvement

Monitor 21

4:30 pm PT

P250

Gender Disparities In Awards Granted by US Allergy/Immunology Societies

Friday, Nov 10

Quality Improvement

Monitor 21

4:45 pm PT

P251

Assessing outcomes of a Dedicated Referral Pathway for Evaluation of Penicillin Allergy During Pregnancy

Friday, Nov 10

Quality Improvement

Monitor 21

5:00 pm PT

P252

Impact of Multi-language Anaphylaxis Plans in an Outpatient Pediatric Allergy Clinic

Friday, Nov 10

Quality Improvement

Monitor 21

5:15 pm PT

P253

Food Insecurity Screening In Food Allergic Patients

Friday, Nov 10

Quality Improvement

Monitor 21

5:30 pm PT

P254

Self-Directed Learning in the Allergy Immunology Clinic: A Quality Improvement Project

Friday, Nov 10

Quality Improvement

Monitor 21

5:45 pm PT

P255

Assessment Of Knowledge Of Identifying Anaphylaxis And EpiPen Usage Among Residents In A Teaching Hospital

Friday, Nov 10

Rhinitis, Other Upper Airway Disorders

Monitor 18

5:15 pm PT

P270

Baseline Corticosteroid Use and Surgery History Among Patients with CRSwNP in Global AROMA registry

Friday, Nov 10

Rhinitis, Other Upper Airway Disorders

Monitor 18

5:30 pm PT

P271

Baseline Disease Burden Among Patients with Chronic Rhinosinusitis with Nasal Polyps in Global AROMA Registry

Friday, Nov 10

Rhinitis, Other Upper Airway Disorders

Monitor 18

5:45 pm PT

P272

Dupilumab Improves Olfaction In Patients With Chronic Rhinosinusitis With Nasal Polyps Irrespective Of Gender

Friday, Nov 10

Skin Disorders

Monitor 20

3:00 pm PT

P280

Maintenance Of Lebrikizumab Efficacy In Moderate-To-Severe Atopic Dermatitis Patients With Stable Asthma Control

Friday, Nov 10

Skin Disorders

Monitor 20

3:15 pm PT

P281

Effect of Delaying First Newborn Bath on the Prevalence of Atopic Dermatitis in Early Childhood

Friday, Nov 10

Skin Disorders

Monitor 20

3:30 pm PT

P282

Tapinarof Cream Improved Itch In Two Phase 3 Trials Of Moderate To Severe Atopic Dermatitis

Friday, Nov 10

Skin Disorders

Monitor 20

3:45 pm PT

P283

Efficacy of Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis

Friday, Nov 10

Skin Disorders

Monitor 20

4:00 pm PT

P284

Once-Daily Roflumilast Cream 0.15% for Atopic Dermatitis: Pooled Results from INTEGUMENT-1/2 Phase 3 Trials

Friday, Nov 10

Skin Disorders

Monitor 20

4:15 pm PT

P285

Assessing Total Corticosteroid Burden in Atopic Dermatitis and Related Atopic Comorbidities

Friday, Nov 10

Skin Disorders

Monitor 20

4:30 pm PT

P286

Safety and Pharmacokinetics of IMG-007, an OX40 monoclonal antibody, in Healthy Adults

Friday, Nov 10

Skin Disorders

Monitor 20

4:45 pm PT

P287

Safety of Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis

Friday, Nov 10

Skin Disorders

Monitor 20

5:00 pm PT

P288-COMMUNITY GRANT

Asthma and Atopic Dermatitis-related Outcomes in Urban Children

Saturday, Nov 11

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

11:35 am PT

P013

Predictive Factors Of Successful Transition To Outpatient For Patients Undergoing Inpatient Desensitization To Chemotherapeutics

Saturday, Nov 11

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

11:50 am PT

P014

Observing patients with anaphylaxis in the Emergency Room: Should we have guidelines?

Saturday, Nov 11

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

12:05 pm PT

P015

The Noise About SARS-COV-2 Vaccination: A Retrospective Cohort Study Evaluating Tinnitus and Vaccination

Saturday, Nov 11

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

12:20 pm PT

P016

A Review of Pediatric Drug-Induced Anaphylaxis Reports in the FDA Adverse Event Reporting System (FAERS)

Saturday, Nov 11

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

12:35 pm PT

P017

Descriptive Analysis of Elevated Serum Tryptase in a Pediatric Cohort

Saturday, Nov 11

Aerobiology, Allergens, Allergen Extracts

Monitor 21

11:35 am PT

P033

Development of Alternaria-sensitization depends on concurrent Malassezia sensitization demonstrating an interplay of sensitizing fungal allergens

Saturday, Nov 11

Aerobiology, Allergens, Allergen Extracts

Monitor 21

11:50 am PT

P034

Longitudinal Prescribing Patterns of Uncommon Mammalian Allergen Immunotherapy across the U.S. Military Healthcare System

Saturday, Nov 11

Aerobiology, Allergens, Allergen Extracts

Monitor 21

12:05 pm PT

P035

Assessing Vertical Airborne Pollen Disparity Using the Novel PollenEyes, a 3D-Printed Rotating Arm Impactor

Saturday, Nov 11

Allergy Diagnostics and Immunotherapy

Monitor 15

12:20 pm PT

P043

Characterizing clinically "relevant" and "irrelevant" adverse reactions to subcutaneous polymerized house dust mite extracts immunotherapy

Saturday, Nov 11

Allergy Diagnostics and Immunotherapy

Monitor 15

12:35 pm PT

P044

Reduced intra-subject variability of Skin Prick Automated Test to detect sensitization to inhalant allergens

Saturday, Nov 11

Angioedema/Urticaria

Monitor 12

11:35 am PT

P062

Remibrutinib Did Not Impact on Total Serum Immunoglobulin Levels of Patients with Chronic Spontaneous Urticaria

Saturday, Nov 11

Angioedema/Urticaria

Monitor 12

11:50 am PT

P063

Highly Sensitive Digital PCR Assay to Detect KIT D816V Mutation in Suspected Mastocytosis Patients

Saturday, Nov 11

Angioedema/Urticaria

Monitor 12

12:05 pm PT

P064

Berotralstat Reduced Attack Rates Compared To Baseline In Patients With Hereditary Angioedema In Apex-S

Saturday, Nov 11

Angioedema/Urticaria

Monitor 12

12:20 pm PT

P065

CRISPR/Cas9 editing of KLKB1 in Hereditary Angioedema Patients: Updated Results from a Phase 1 Study

Saturday, Nov 11

Angioedema/Urticaria

Monitor 12

12:35 pm PT

P066

Support for STAR-0215 Administered Every Three- or Six-Months for Hereditary Angioedema: Phase 1a Results

Saturday, Nov 11

Angioedema/Urticaria

Monitor 13

11:35 am PT

P084

Long-term quality-of-life and patient-reported improvements with garadacimab for hereditary angioedema: Phase 3 open-label extension study

Saturday, Nov 11

Angioedema/Urticaria

Monitor 13

11:50 am PT

P085

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Saturday, Nov 11

Angioedema/Urticaria

Monitor 13

12:05 pm PT

P086

Real-World Quality of Life in Patients with HAE Receiving Lanadelumab or Other Long-Term Prophylaxis

Saturday, Nov 11

Angioedema/Urticaria

Monitor 13

12:20 pm PT

P087

Reasons Not To Treat HAE Attacks And Satisfaction For On-Demand Treatment

Saturday, Nov 11

Angioedema/Urticaria

Monitor 13

12:35 pm PT

P088

Remibrutinib Showed Good Stability of Response in Patients With Chronic Spontaneous Urticaria: Phase 2b Study

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 14

11:35 am PT

P112

Efficacy and Safety of Dupilumab in Preschool Children With Atopic Dermatitis and Type 2 Comorbidities

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 14

11:50 am PT

P113

Association between neighborhood deprivation index and asthma exacerbation and utilization among individuals with intermittent asthma

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 14

12:05 pm PT

P114

Biologic Outcomes Among Adults with Severe Asthma by Age of Onset: Results from CHRONICLE

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 14

12:20 pm PT

P115

Safety of As-needed Albuterol-budesonide by Background Inhaled Corticosteroid Maintenance Dose in Adults with Moderate-to-severe Asthma

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 14

12:35 pm PT

P116

Perceptions On Use Of A Shared Decision-Making Guide Among Minoritized Patients With Asthma

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 15

11:35 am PT

P134

Coexisting Chronic Rhinosinusitis with Nasal Polyps in Patients With Moderate-to-Severe Asthma: The RAPID registry study

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 15

11:50 am PT

P135

Risk Factors of Asthma Exacerbations in Patients with Intermittent Asthma

Saturday, Nov 11

Asthma, Other Lower Airway Disorders

Monitor 15

12:05 pm PT

P136

Blood Eosinophil Level Changes With Biologic Initiation: Real-world Data From The CHRONICLE Study

Saturday, Nov 11

Clinical Immunology, Immunodeficiency

Monitor 16

11:35 am PT

P162

CD14 (C-159)T Gene Polymorphism in SARS-CoV-2 Patients in Crimea

Saturday, Nov 11

Clinical Immunology, Immunodeficiency

Monitor 16

11:50 am PT

P163

Oxalic Acid Levels Impact Cytokine Production Leading to Greater Chronic Inflammation in Chronic Kidney Diseases

Saturday, Nov 11

Clinical Immunology, Immunodeficiency

Monitor 16

12:20 pm PT

P165

Mortality in Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS), a Systematic Literature Review (SLR)

Saturday, Nov 11

Clinical Immunology, Immunodeficiency

Monitor 16

12:35 pm PT

P166

Overall Survival (OS) Among Patients With Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)

Saturday, Nov 11

Clinical Immunology, Immunodeficiency

Monitor 16

12:05 pm PT

P169-INTL SCHOLARSHIP AWARDEE

Specific Antibody Defect in Bronchiectasis of Unknown Aetiology

Saturday, Nov 11

Food Allergy

Monitor 17

11:35 am PT

P192

Parent Perspectives on Peanut Allergy Oral Immunotherapy Timing for Young Children

Saturday, Nov 11

Food Allergy

Monitor 17

11:50 am PT

P193

Addressing the Research Participation Gap in Food Allergy

Saturday, Nov 11

Food Allergy

Monitor 17

12:05 pm PT

P194

Why Do Those Who Need an Epinephrine Autoinjector Not Carry It?: A Customer Discovery Approach

Saturday, Nov 11

Food Allergy

Monitor 17

12:20 pm PT

P195-COMMUNITY GRANT

Adolescents demonstrate improved comfort with self-management of food allergies with implementation of tailored education visit

Saturday, Nov 11

Food Allergy

Monitor 17

12:35 pm PT

P196

Allergist Access as a Potential Driver of Socioeconomic Disparities in Food Allergy

Saturday, Nov 11

Other Eosinophilic granulomatosis with polyangiitis

Monitor 19

11:35 am PT

P237

Effects of Mepolizumab on Patients With Eosinophilic Granulomatosis With Polyangiitis in the United States

Saturday, Nov 11

Other Eye allergy

Monitor 19

11:50 am PT

P238

Allergic profile in pediatric keratoconus on a third level hospital in northeastern Mexico

Saturday, Nov 11

Other Fellowship Consultation and Training

Monitor 19

12:05 pm PT

P239

TREC Screening Results Have Emerged as a Key Reason for Inpatient Pediatric Allergy/Immunology Consultation

Saturday, Nov 11

Other Health disparity

Monitor 19

12:20 pm PT

P240

Language Barriers are Associated with the Underdiagnosis of Allergy and Immunology Conditions in Children

Saturday, Nov 11

Other Mastocytosis

Monitor 19

12:35 pm PT

P241

Avapritinib Improved Gastrointestinal Symptoms in Patients With Indolent Systemic Mastocytosis: Registrational Double-Blind, Placebo-Controlled PIONEER Study

Saturday, Nov 11

Quality Improvement

Monitor 20

12:20 pm PT

P258

Hybrid Telemedicine For Patient Care: Insights From A Patient Satisfaction Survey

Saturday, Nov 11

Quality Improvement

Monitor 20

12:35 pm PT

P259

A Quality Improvement Initiative Increasing Formal Evaluations of Unconfirmed Penicillin Allergies in a Pediatric Hospital

Saturday, Nov 11

Quality Improvement

Monitor 21

12:20 pm PT

P260

An Evaluation Of Outcomes In Penicillin Allergic Stem Cell Transplant Patients

Saturday, Nov 11

Quality Improvement

Monitor 21

12:35 pm PT

P261

Assessment of Pediatrics Resident Knowledge Regarding Epinephrine Autoinjectors

Saturday, Nov 11

Rhinitis, Other Upper Airway Disorders

Monitor 18

11:35 am PT

P273

Assessing the Effects of Area Deprivation Index on Outcome Measures in Patients with Chronic Rhinosinusitis

Saturday, Nov 11

Rhinitis, Other Upper Airway Disorders

Monitor 18

11:50 am PT

P274

Joint Pain and Sinus Scores in 3 Populations of Aspirin-Exacerbated Respiratory Disease Patients

Saturday, Nov 11

Rhinitis, Other Upper Airway Disorders

Monitor 18

12:05 pm PT

P275

Actigraphy as an Objective Measure of Sleep Disruption in Chronic Rhinosinusitis

Saturday, Nov 11

Skin Disorders

Monitor 20

11:35 am PT

P289

Atopic Dermatitis Patient Experience With Discussing and Addressing Mental Health Concerns with Allergists

Saturday, Nov 11

Skin Disorders

Monitor 20

11:50 am PT

P290

Allergic Diseases and Allergen Sensitization in Patients with Alopecia Areata

Saturday, Nov 11

Skin Disorders

Monitor 20

12:05 pm PT

P291

Atopic & Inflammatory Skin Conditions Amongst People Experiencing Homelessness: Insights from Miami Street Medicine

Sunday, Nov 12

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

11:35 am PT

P018

Effect of Upper Respiratory Tract Infection on the Pharmacokinetics and Pharmacodynamics of Intranasal Epinephrine

Sunday, Nov 12

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

11:50 am PT

P019

Healthcare Disparities Investigated in an Innovative Multicenter General Pediatric Directed Pathway to Remove Penicillin Allergies

Sunday, Nov 12

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

12:05 pm PT

P020

Improving the Management of Pediatric Anaphylaxis in the Emergency Department at a Tertiary Care Hospital

Sunday, Nov 12

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

12:20 pm PT

P021

Risk Factors For Systemic Reactions In Rush Aeroallergen Immunotherapy

Sunday, Nov 12

Adverse Drug Reactions, Insect Reactions, Anaphylaxis

Monitor 11

12:35 pm PT

P022

Outcomes of Patients with Left Ventricular Assisted Device (LVAD) and Penicillin-Allergy Label

Sunday, Nov 12

Aerobiology, Allergens, Allergen Extracts

Monitor 21

11:35 am PT

P036

A Breath of Fresh Information on Air Cleaning Technology

Sunday, Nov 12

Aerobiology, Allergens, Allergen Extracts

Monitor 21

11:50 am PT

P037

Health Consequences and Remediation of Mold Exposure Following Natural Disasters: A Scoping Review

Sunday, Nov 12

Allergy Diagnostics and Immunotherapy

Monitor 15

12:20 pm PT

P045

Minimally Invasive Point of Care Total IgE Quantification is Clinically Equivalent to Laboratory Reference Standard

Sunday, Nov 12

Allergy Diagnostics and Immunotherapy

Monitor 15

12:35 pm PT

P046

Preferred Allergy Immunotherapy Treatment and Needle Phobia Among Children with Allergic Rhinitis: Survey Results

Sunday, Nov 12

Angioedema/Urticaria

Monitor 12

11:35 am PT

P067

Real-World Effectiveness of Omalizumab in Patients Treated for Chronic Spontaneous Urticaria

Sunday, Nov 12

Angioedema/Urticaria

Monitor 12

11:50 am PT

P068

Perspectives of Medical Care Among Patients With Hereditary Angioedema Within Underrepresented Racial or Ethnic Groups

Sunday, Nov 12

Angioedema/Urticaria

Monitor 12

12:05 pm PT

P069

Diagnosing Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) – A Real World ACARE Survey

Sunday, Nov 12

Angioedema/Urticaria

Monitor 12

12:20 pm PT

P070

Refining Prevalence Estimates of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH)

Sunday, Nov 12

Angioedema/Urticaria

Monitor 12

12:35 pm PT

P071

Efficacy and Safety of CT-P39 compared to Reference Omalizumab in Patients with Chronic Spontaneous Urticaria

Sunday, Nov 12

Angioedema/Urticaria

Monitor 13

11:35 am PT

P089

Relationship Between D-Dimer Levels And Clinical Activity Of Spontaneous Chronic Urticaria.

Sunday, Nov 12

Angioedema/Urticaria

Monitor 13

11:50 am PT

P090

Omalizumab Use in Patients with Chronic Spontaneous Urticaria: A Real-World Survey in the United States

Sunday, Nov 12

Angioedema/Urticaria

Monitor 13

12:05 pm PT

P091

Burden of Hereditary Angioedema: Findings from a Multinational Survey of Caregivers for Adult Patients

Sunday, Nov 12

Angioedema/Urticaria

Monitor 13

12:20 pm PT

P092

Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 14

11:35 am PT

P117

Dupilumab Efficacy in Children With/Without Allergic Asthma in the Presence of Elevated Type 2 Biomarkers

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 14

11:50 am PT

P118

Dupilumab Reduces Corticosteroid Use in Children With Uncontrolled Moderate-to-severe Asthma Regardless of Exacerbation History

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 14

12:05 pm PT

P119

Assessment of the Immune Status in Obese Asthma Patients

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 14

12:20 pm PT

P120

Fractional Exhaled Nitric Oxide (FeNO) is a Stable Biomarker in Patients with Uncontrolled Asthma

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 14

12:35 pm PT

P121

Trusted Messenger Virtual Asthma Coaching Intervention Impacts Asthma Self-Management

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 15

11:35 am PT

P137

Randomized attention-placebo controlled trial of a digital self-management platform for adult asthma

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 15

11:50 am PT

P138

Respiratory Functions in Girls with Varying Levels of Physical Activity

Sunday, Nov 12

Asthma, Other Lower Airway Disorders

Monitor 15

12:05 pm PT

P139

Association Between Baseline Characteristics and Oral Corticosteroid Reduction in Patients With Oral Corticosteroid-Dependent Severe Asthma

Sunday, Nov 12

Clinical Immunology, Immunodeficiency

Monitor 16

11:35 am PT

P167

Clinical Assessment of Safety, Pharmacokinetics, and Efficacy of Immune Globulin Intravenous 10% in Pediatric Patients

Sunday, Nov 12

Clinical Immunology, Immunodeficiency

Monitor 16

11:50 am PT

P168

SARS-CoV2 Specific Antibody Responses to COVID-19 Vaccination in Common Variable Immunodeficiency

Sunday, Nov 12

Clinical Immunology, Immunodeficiency

Monitor 16

12:20 pm PT

P170

Long-Term Outcomes with Immune Globulin Subcutaneous 16.5% in Treatment of Primary Immunodeficiency

Sunday, Nov 12

Clinical Immunology, Immunodeficiency

Monitor 16

12:35 pm PT

P171

Nasal Powder Methyl-cellulose Alone or with European Wild Garlic as Mucosal Barrier Against Viruses

Sunday, Nov 12

Food Allergy

Monitor 17

11:35 am PT

P197

Using Instagram to Provide High-Quality Food Allergy Education and Awareness

Sunday, Nov 12

Food Allergy

Monitor 17

11:50 am PT

P198

Food Allergies Associations with Anxiety and Depression Disorders in the US General Population

Sunday, Nov 12

Food Allergy

Monitor 17

12:05 pm PT

P199

Methodology of the Cross-Sectional Study for Global Prevalence and Severity of Food Allergies (ASSESS FA)

Sunday, Nov 12

Food Allergy

Monitor 17

12:20 pm PT

P200

Food Allergies and Autism Spectrum Disorder: A Comparative Study of Sensitization in Children.

Sunday, Nov 12

Food Allergy

Monitor 17

12:35 pm PT

P201

Impact of dupilumab on food-specific IgE levels

Sunday, Nov 12

Other Medicare Reimbursement Trends in Allergy/Immunology

Monitor 19

11:35 am PT

P242

Changes in Medicare Reimbursement for Allergy and Immunology Procedures: A State-by-State Analysis 2013-2022

Sunday, Nov 12

Other Medication Adherence

Monitor 19

11:50 am PT

P243

HealthBeacon's Injection Care Management System (ICMS); Improving Adherence to Injectable Medication for Respiratory Disease

Sunday, Nov 12

Other SARS-CoV-2 infection

Monitor 19

12:05 pm PT

P244

Double blind randomized controlled trial of saline solution gargling and nasal rinsing in SARS-CoV-2 infection

Sunday, Nov 12

Other Stomach or GI

Monitor 19

12:20 pm PT

P245

A Study of Dupilumab Versus Placebo in Patients With Eosinophilic Gastritis With/Without Eosinophilic Duodenitis

Sunday, Nov 12

Quality Improvement

Monitor 20

12:20 pm PT

P256

Continued Evaluation Of Penicillin Allergy Delabeling And The Impact Of Resident Education On Current Efforts

Sunday, Nov 12

Quality Improvement

Monitor 20

12:35 pm PT

P257

Evaluation of an Allergy and Immunology Handbook to Improve Medical Education for Fellows

Sunday, Nov 12

Quality Improvement

Monitor 21

12:20 pm PT

P262

Building a Pediatric Drug Allergy Evaluation Program

Sunday, Nov 12

Quality Improvement

Monitor 21

12:35 pm PT

P263

Why Tolerate Food Intolerance

Sunday, Nov 12

Rhinitis, Other Upper Airway Disorders

Monitor 18

11:35 am PT

P276

Impacts of Tethered Education for Clinicians and Patients in Management of Severe Nasal Polyps (NPs)

Sunday, Nov 12

Rhinitis, Other Upper Airway Disorders

Monitor 18

11:50 am PT

P277

Improved sleep quality and timing in patients with Chronic-rhinosinusitis after use of deep-delivery nasal corticosteroid

Sunday, Nov 12

Skin Disorders

Monitor 20

11:35 am PT

P292

Seum IgE reduction after dupilumab therapy in patients with atopic dermatitis in southern Puerto Rico

Sunday, Nov 12

Skin Disorders

Monitor 20

11:50 am PT

P293

Common Contact Allergens Found by Patch Testing in the Allergist’s Office

Sunday, Nov 12

Skin Disorders

Monitor 20

12:05 pm PT

P294

Empowering People of Color (POC) with Moderate-to-severe Atopic Dermatitis to Advocate for Multidisciplinary Care

No FAQ Found

Back to Top